News & Events

Noteworthy developments & upcoming engagements in the global scientific community


CiPA – Novel safety screening initiative driven by HESI, FDA and Safety Pharmacology Society Drug toxicity is a pervasive issue … Continued

Cardiomyocyte Maturation

Functional Maturation of hiPSC-CMs Utility of hiPSC-CMs for Truly Predictive Assays Human iPSC-CM’s inherent morphology, structural hallmarks, calcium handling mechanism, … Continued

Cardiac Disease Modeling

Human iPSC-Cardiomyocytes for Cardiac Disease Modeling The pathophysiological cellular phenotypes of genetically heritable heart diseases can be modeled using disease-specific … Continued

Cardiac Drug Discovery

Innovate Your Approach to Drug Discovery Dynamic and intricate monitoring of the excitation-contraction process of cardiomyocytes The 5-year mortality rate … Continued

Preclinical In Vitro Cardiac Toxicity

Contractile Activity + Electrophysiological Activity + Viability -> Real Time Cell Analysis of Toxicity Cardiomyocytes for the predictive assessments of … Continued

Cardiomyocyte Functional Assays

Physiologically Relevant Cell Types with Real-Time Cell Analysis for More Predictive Assays   Continuous real-time cell analysis improves on the … Continued


現在実施されているIn vitroアッセイの結果とIn vivoの結果の違いにお困りではありませんか? xCELLigence® Real-Time Cell Analysis (RTCA)アナライザーを使えばin vitroとin vivoで整合性のある結果が得られます: ラベルフリー: アイソトープ 51Cr, ルシフェラーゼ、染色色素などの添加は一切不要。 使用方法は至って簡単: ターゲットを播種してエフェクターを加えるだけ。 96ウェルすべてを15秒以内に測定完了。 最高プレート6枚まで別々に測定可能。 測定頻度は数秒から数日で対応可能。 驚きの感度: … Continued

Cancer Immunotherapy: Oncolytic Viruses

Oncolytic virotherapy is a promising cancer treatment that uses a replication-competent virus to selectively infect cancer cells, cause cytotoxicity, and … Continued

Cancer Immunotherapy: Combination Therapy

The traditional oncology pharmacopia of small molecules is rapidly being supplemented with biologics such as checkpoint inhibitors, and will soon … Continued

Cancer Immunotherapy: Checkpoint Inhibitors

By disrupting the signaling pathways that normally suppress immune cell activation, checkpoint inhibitors enable immune effector cells to attack cancer … Continued